Lithium profoundly prevents brain damage associated with Parkinson's disease
June 24, 2011 in Parkinson's & Movement disordersLithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.
Preclinical research is now underway at the Buck Institute for Research on Aging to determine correct dosages for a drug that continues to be the gold standard for the treatment of bipolar disorder. The Buck is currently working toward initiating a Phase IIa clinical studies of lithium in humans in conjunction with standard PD drug therapy. The research appears in the June 24 online edition of the Journal of Neuroscience Research.
"This is the first time lithium has been tested in an animal model of PD," said lead author and Buck Professor Julie Andersen, PhD. "The fact that lithium's safety profile in humans is well understood greatly reduces trial risk and lowers a significant hurdle to getting it into the clinic."
According to Andersen, lithium has recently been suggested to be neuroprotective in relation to several neurodegenerative conditions including Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis and has been touted for its anti-aging properties in simple animals. "We fed our mice levels of lithium that were at the low end of the therapeutic range," said Andersen. "The possibility that lithium could be effective in PD patients at subclinical levels is exciting, because it would avoid many side effects associated at the higher dose range." Overuse of lithium has been linked to hyperthyroidism and kidney toxicity.
PD is a progressive, incurable neurodegenerative disorder that affects 1 million Americans and results in tremor, slowness of movement and rigidity. It is the second most common neurodegenerative disease after Alzheimer's. Between 50,000 and 60,000 new cases are diagnosed each year. Age is the largest risk factor for the PD. Onset usually begins between the ages of 45 and 70 years.
Andersen's research focuses on lithium as a potential treatment for PD as well as its efficacy in combination with drugs currently used to control the symptoms of the disease. An internet search reveals stories from PD patients who are using lithium "off label" as part of their treatment regime; others report benefits from low dose lithium salts which are available as a supplement in some health food stores. "This finding gives us an opportunity to explore lithium as a recognized therapeutic for PD, in doses that are safe and effective" said Andersen.
More information: Lithium protects against oxidative stress-mediated cell death in alpha-synuclein over-expressing in vitro and in vivo models of Parkinson's disease. JNR: 852471-744204
Provided by Buck Institute for Age Research
-
Anti-Inflammatory Drug Reduces Nerve Death in Mouse Model of Parkinson's Disease
Nov 07, 2006 |
not rated yet |
0
-
Buck research focuses on risk factor for Parkinson's disease
Feb 20, 2008 |
not rated yet |
0
-
Reducing the toxicity of lithium
Jun 08, 2010 |
not rated yet |
0
-
New light on bipolar treatment drugs
Apr 21, 2009 |
not rated yet |
0
-
Researchers identify genes associated with onset age of Parkinson's disease
Oct 07, 2009 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
a numerical problem...kindly provide d solution
8 hours ago
-
energy and momentum conservation
8 hours ago
-
Uniform circular motion (centripetal acceleration & force)
11 hours ago
-
Rotational Mechanics: Sphere collision problem
16 hours ago
-
Combustion Model
16 hours ago
-
Properties of Cathode Rays
16 hours ago
- More from Physics Forums - Classical Physics
More news stories
Study supports urate protection against Parkinson's disease, hints at novel mechanism
Use of the antioxidant urate to protect against the neurodegeneration caused by Parkinson's disease appears to rely on more than urate's ability to protect against oxidative damage. In the May issue of the open-access journal ...
Parkinson's & Movement disorders
May 23, 2012 |
not rated yet |
0
|
Molecular 'on-off' switch for Parkinson's disease discovered
(Medical Xpress) -- Scientists at the Medical Research Council (MRC) Protein Phosphorylation Unit at the University of Dundee have discovered a new molecular switch that acts to protect the brain from developing Parkinson's ...
Parkinson's & Movement disorders
May 23, 2012 |
5 / 5 (8) |
0
|
Study IDs gene variants that speed progression of Parkinson's disease
UCLA researchers may have found a key to determining which Parkinson's disease patients will experience a more rapid decline in motor function, sparking hopes for the development of new therapies and helping identify those ...
Parkinson's & Movement disorders
May 15, 2012 |
not rated yet |
0
|
Colonoscopy or flexible sigmoidoscopy may be used to predict Parkinson's
Two studies by neurological researchers at Rush University Medical Center suggest that, in the future, colonic tissue obtained during either colonoscopy or flexible sigmoidoscopy may be used to predict who will develop Parkinson's ...
Parkinson's & Movement disorders
May 15, 2012 |
not rated yet |
0
Vitamin K2: New hope for Parkinson's patients?
Neuroscientist Patrik Verstreken, associated with VIB and KU Leuven, succeeded in undoing the effect of one of the genetic defects that leads to Parkinson's using vitamin K2. His discovery gives hope to Parkinson's patients. ...
Parkinson's & Movement disorders
May 11, 2012 |
not rated yet |
0
Amino acid consumption associated with how fast cancer cells divide
For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...
'Personality genes' may help account for longevity
"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...
Gene discovery points towards non-hormonal male contraceptive
A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Cyber exercise partners help you go the distance: Motivation gains can double
A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation by as much as 100 percent ...
Brentuximab vedotin effective in large-cell lymphoma
(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...